Polianta Ltd’s Jazz Pharmaceuticals JAZZ Stock Holding History

Polianta Ltd’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-9,700	Closed	-$1.26M	–	82
2021 Q3	$1.26M	Buy	+9,700	New	+$1.47M	0.59%	37
2020 Q2	–	Sell	-7,900	Closed	-$787K	–	86
2020 Q1	$787K	Buy	+7,900	New	+$1.02M	0.54%	45
2019 Q3	–	Sell	-8,350	Closed	-$1.19M	–	87
2019 Q2	$1.19M	Buy	+8,350	New	+$1.12M	0.51%	19

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Polianta Ltd's JAZZ Position: Q4 2021 in Review

Polianta Ltd sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2021, closing a stake of 9,700 shares — an estimated $1.26M sold.

Polianta Ltd first reported a position in JAZZ in Q2 2019 and held it in 3 quarters. The position peaked at $1.26M in Q3 2021. 454 funds tracked by Wall St. Rank hold JAZZ as of Q4 2021.

Polianta Ltd reported no remaining Jazz Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
Polianta Ltd sold 9,700 Jazz Pharmaceuticals shares in Q4 2021, an estimated $1.26M.
Polianta Ltd first reported a position in Jazz Pharmaceuticals in Q2 2019 and held it in 3 quarters.
Polianta Ltd's Jazz Pharmaceuticals position peaked at $1.26M in Q3 2021.
454 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2021.

Based on Polianta Ltd's 13F filing for Q4 2021, filed 18 Jan 2022.